Kossel MedTech is positioned as a platform enterprise with comprehensive R&D production capacity for vascular intervention. With a full range of balloon catheters, metal stents, drug-eluting stents, cryoablation and shockwave, and other passive and active technology platforms, including medical devices of 3 intervention categories of coronary, peripheral vascular, electrophysiology.
Kossel MedTech is committed to developing a one-stop treatment system in the field of peripheral intervention. For peripheral venous diseases, in addition to the vena cava filter, PTA balloon catheter, the company is developing a series of products for volume reduction treatment; for peripheral artery disease, we are developing a series of products to treat arterial stenosis and arterial calcium.
Except for peripheral intervention, Kossel Medtech subsidiary Suzhou Haiyu Medtech Co., Ltd. concentrated field of cardiac electrophysiology. Tachyarrhythmia treatment provides a full range of solutions. Its Steerable Curve Diagnostic Catheter, Diagnostic Electrophysiology Catheter, and Cardiac Ablation Catheter have been approved by the NMPA (National Medical Products Administration). Also develop balloon cryoablation system and related pathway products.
Mixin Medtech(Suzhou) Co., Ltd, another subsidiary of Kossel Medtech, focuses on the field of coronary intervention products and the transformation of overseas products and technologies. Its products such as CTO (chronic complete occlusion disease) balloon catheter, PTCA balloon catheter, and coronary stent system have been marketed and sold. The Selebrek®CTO balloon catheter, PTCA balloon catheter and NC PTCA balloon catheter have been FDA approved. And have entered Japan, the United States, South Korea, Europe and other mainstream markets.
Adhering to the concept of “coming from the clinic, serving the clinic”, Kossel Medtech has carried out fruitful scientific research cooperation with many well-known hospitals, clinical departments, and universities in China. In addition, Kossel medtech unswervingly implements the overseas expansion strategy, actively develops overseas business, insists on win-win cooperation, “goes out, brings in”, and improves the overall technical level of the company.
